China is sprucing up its pharma sector

Against the backdrop of regulatory tightening, quarterly growth started to slow again from 6.8% YoY to 6.7% in Q2 and further to 6.5% in Q3 amid persisting trade uncertainties.

Policy easing has made its way back, but regulatory tightening to mitigate environmental and financial risk will remain definite drags on growth.